UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Amica Retiree Medical Trust

Amica Retiree Medical Trust trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,655 shares of the healthcare conglomerate’s stock after selling 230 shares during the period. UnitedHealth Group comprises 1.3% of Amica Retiree Medical Trust’s investment portfolio, making the stock its 14th biggest holding. Amica Retiree Medical Trust’s holdings in UnitedHealth Group were worth $1,343,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of UNH. Homestead Advisers Corp purchased a new stake in UnitedHealth Group during the fourth quarter worth about $28,429,000. AssuredPartners Investment Advisors LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth $3,640,000. NEOS Investment Management LLC raised its position in UnitedHealth Group by 24.1% during the fourth quarter. NEOS Investment Management LLC now owns 48,357 shares of the healthcare conglomerate’s stock worth $24,462,000 after acquiring an additional 9,403 shares during the last quarter. BIT Capital GmbH purchased a new stake in UnitedHealth Group in the 4th quarter valued at approximately $943,000. Finally, UniSuper Management Pty Ltd increased its position in UnitedHealth Group by 14.0% during the 4th quarter. UniSuper Management Pty Ltd now owns 102,789 shares of the healthcare conglomerate’s stock worth $51,997,000 after purchasing an additional 12,587 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on UNH. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Oppenheimer increased their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. KeyCorp reaffirmed an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Piper Sandler cut their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Finally, StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Twenty analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Stock Up 0.9 %

Shares of UnitedHealth Group stock opened at $518.10 on Thursday. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a market cap of $473.92 billion, a P/E ratio of 33.43, a P/E/G ratio of 1.37 and a beta of 0.62. The business has a 50-day moving average price of $508.60 and a 200 day moving average price of $545.37.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the company earned $5.83 earnings per share. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.62%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.